140 related articles for article (PubMed ID: 9059655)
1. Aldose reductase as dihydrodiol dehydrogenase. Naphthoquinone formation by rat lens aldose reductase.
Sato S; Sugiyama K; Carper D
Adv Exp Med Biol; 1997; 414():499-505. PubMed ID: 9059655
[No Abstract] [Full Text] [Related]
2. Prevention of naphthalene-1,2-dihydrodiol-induced lens protein modifications by structurally diverse aldose reductase inhibitors.
Sato S; Sugiyama K; Lee YS; Kador PF
Exp Eye Res; 1999 May; 68(5):601-8. PubMed ID: 10328974
[TBL] [Abstract][Full Text] [Related]
3. The distribution of aldose reductase and aldehyde reductase II in different regions of bovine lens.
Liu S; Das B; Srivastava SK
Lens Eye Toxic Res; 1989; 6(3):415-30. PubMed ID: 2518623
[TBL] [Abstract][Full Text] [Related]
4. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.
Kador PF; Lee JW; Fujisawa S; Blessing K; Lou MF
J Ocul Pharmacol Ther; 2000 Apr; 16(2):149-60. PubMed ID: 10803425
[TBL] [Abstract][Full Text] [Related]
5. Aldose reductase the major protein associated with naphthalene dihydrodiol dehydrogenase activity in rat lens.
Sato S
Invest Ophthalmol Vis Sci; 1993 Oct; 34(11):3172-8. PubMed ID: 8407226
[TBL] [Abstract][Full Text] [Related]
6. Human kidney aldose and aldehyde reductases.
Sato S; Kador PF
J Diabetes Complications; 1993; 7(3):179-87. PubMed ID: 8343612
[TBL] [Abstract][Full Text] [Related]
7. Isolation of a non-covalent aldose reductase-nucleotide-inhibitor complex.
Sugiyama K; Chen Z; Lee YS; Kador PF
Biochem Pharmacol; 2000 Feb; 59(4):329-36. PubMed ID: 10644040
[TBL] [Abstract][Full Text] [Related]
8. Activation of aldose reductase in rat lens and metal-ion chelation by aldose reductase inhibitors and lipoic acid.
Ou P; Nourooz-Zadeh J; Tritschler HJ; Wolff S
Free Radic Res; 1996 Oct; 25(4):337-46. PubMed ID: 8889497
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of aldehyde reductase by aldose reductase inhibitors.
Sato S; Kador PF
Biochem Pharmacol; 1990 Sep; 40(5):1033-42. PubMed ID: 2117925
[TBL] [Abstract][Full Text] [Related]
10. The effect of non-enzymatic glycation on recombinant human aldose reductase.
Yamaoka T; Oda A; Bannai C; Itakura M; Yamashita K
Diabetes Res Clin Pract; 1995 Mar; 27(3):165-9. PubMed ID: 7555597
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of naphthalene cataract in rats by aldose reductase inhibitors.
Lou MF; Xu GT; Zigler S; York B
Curr Eye Res; 1996 Apr; 15(4):423-32. PubMed ID: 8670742
[TBL] [Abstract][Full Text] [Related]
12. Comparison of aldose reductase inhibitors in vitro. Effects of enzyme purification and substrate type.
Poulsom R
Biochem Pharmacol; 1987 May; 36(10):1577-81. PubMed ID: 3109423
[TBL] [Abstract][Full Text] [Related]
13. Determination of aldose reductase activity in the eye by localized magnetic resonance spectroscopy.
Lizak MJ; Mori K; Kador PF
J Ocul Pharmacol Ther; 2001 Oct; 17(5):475-83. PubMed ID: 11765152
[TBL] [Abstract][Full Text] [Related]
14. Aldose reductase catalyzes the oxidation of naphthalene-1, 2-dihydrodiol for the formation of ortho-naphthoquinone.
Sugiyama K; Wang TC; Simpson JT; Rodriguez L; Kador PF; Sato S
Drug Metab Dispos; 1999 Jan; 27(1):60-7. PubMed ID: 9884310
[TBL] [Abstract][Full Text] [Related]
15. Aldose reductase in diabetic cataracts.
Kinoshita JH; Kador P; Catiles M
JAMA; 1981 Jul; 246(3):257-61. PubMed ID: 6787220
[No Abstract] [Full Text] [Related]
16. Aldose reductase inhibitors as pathobiochemical probes.
Dvornik D
J Diabetes Complications; 1992; 6(1):25-34. PubMed ID: 1562755
[TBL] [Abstract][Full Text] [Related]
17. Kinetic and spectroscopic evidence for active site inhibition of human aldose reductase.
Nakano T; Petrash JM
Biochemistry; 1996 Aug; 35(34):11196-202. PubMed ID: 8780524
[TBL] [Abstract][Full Text] [Related]
18. Aldose reductases from human retina and bovine lens: dependence of inhibition upon the choice of enzyme substrate.
Poulsom R
Prog Clin Biol Res; 1987; 232():341-52. PubMed ID: 3112787
[No Abstract] [Full Text] [Related]
19. Studies on L-threose as substrate for aldose reductase: a possible role in preventing protein glycation.
Devamanoharan PS; Varma SD
Mol Cell Biochem; 1996 Jun; 159(2):123-7. PubMed ID: 8858562
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and aldose reductase inhibitory activity of 2-substituted-6-fluoro-2,3-dihydrospiro [4H-1-benzopyran-4, 4'-imidazolidine]-2',5'-diones.
Yamaguchi T; Miura K; Usui T; Unno R; Matsumoto Y; Fukushima M; Mizuno K; Kondo Y; Baba Y; Kurono M
Arzneimittelforschung; 1994 Mar; 44(3):344-8. PubMed ID: 8192700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
